Found: 68
Select item for more details and to access through your institution.
The effects of maternal age and parity on maternal and neonatal outcome.
- Published in:
- Archives of Gynecology & Obstetrics, 2015, v. 291, n. 4, p. 793, doi. 10.1007/s00404-014-3469-0
- By:
- Publication type:
- Article
Prospective study of maternal and neonatal outcome in great-grand multiparous women (≥10 births) and in aged-matched women with lesser parity.
- Published in:
- Archives of Gynecology & Obstetrics, 2011, v. 284, n. 4, p. 799, doi. 10.1007/s00404-010-1722-8
- By:
- Publication type:
- Article
FindZebra online search delving into rare disease case reports using natural language processing.
- Published in:
- PLoS Digital Health, 2023, v. 1, n. 6, p. 1, doi. 10.1371/journal.pdig.0000269
- By:
- Publication type:
- Article
Outcome of ten years' echocardiographic follow-up in children with Gaucher disease.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Bone Mineral Density in Gravida: Effect of Pregnancies and Breast-Feeding in Women of Differing Ages and Parity.
- Published in:
- Journal of Osteoporosis, 2014, p. 1, doi. 10.1155/2014/897182
- By:
- Publication type:
- Article
Ethical considerations for enzyme replacement therapy in neuronopathic Gaucher disease.
- Published in:
- Clinical Genetics, 1998, v. 54, n. 3, p. 179, doi. 10.1111/j.1399-0004.1998.tb04281.x
- By:
- Publication type:
- Article
Effect of cyclic, low dose pyrimethamine treatment in patients with Late Onset Tay Sachs: an open label, extended pilot study.
- Published in:
- Orphanet Journal of Rare Diseases, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13023-015-0260-7
- By:
- Publication type:
- Article
Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease.
- Published in:
- Orphanet Journal of Rare Diseases, 2013, v. 8, n. 1, p. 1, doi. 10.1186/1750-1172-8-151
- By:
- Publication type:
- Article
Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Requests and usage of epidural analgesia in grand-grand multiparous and similar-aged women with lesser parity: prospective observational study.
- Published in:
- Journal of Perinatal Medicine, 2011, v. 39, n. 6, p. 697, doi. 10.1515/JPM.2011.088
- By:
- Publication type:
- Article
Retrospective audit of outcome of regional anesthesia for delivery in women with thrombocytopenia.
- Published in:
- Journal of Perinatal Medicine, 2008, v. 36, n. 2, p. 120, doi. 10.1515/JPM.2008.020
- By:
- Publication type:
- Article
Outcome of pregnancies in women receiving velaglucerase alfa for Gaucher disease.
- Published in:
- Journal of Obstetrics & Gynaecology Research, 2014, v. 40, n. 4, p. 968, doi. 10.1111/jog.12254
- By:
- Publication type:
- Article
Review of the safety and efficacy of imiglucerase treatment of Gaucher disease.
- Published in:
- Biologics: Targets & Therapy, 2009, v. 3, p. 407
- By:
- Publication type:
- Article
Glucosylsphingosine Is a Highly Sensitive and Specific Biomarker for Primary Diagnostic and Follow-Up Monitoring in Gaucher Disease in a Non-Jewish, Caucasian Cohort of Gaucher Disease Patients.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0079732
- By:
- Publication type:
- Article
Poor results of drilling in early stages of juxta-articular osteonecrosis in 12 joints affected by Gaucher disease.
- Published in:
- Acta Orthopaedica, 2009, v. 80, n. 2, p. 201, doi. 10.3109/17453670902930032
- By:
- Publication type:
- Article
Twelve Years of the Gaucher Outcomes Survey (GOS): Insights, Achievements, and Lessons Learned from a Global Patient Registry.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 12, p. 3588, doi. 10.3390/jcm13123588
- By:
- Publication type:
- Article
Long-Term Treatment of Gaucher Disease with Velaglucerase Alfa in ERT-Naïve Patients from the Gaucher Outcome Survey (GOS) Registry.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 10, p. 2782, doi. 10.3390/jcm13102782
- By:
- Publication type:
- Article
ASPECTS OF PATIENT REPORTED OUTCOMES IN RARE DISEASES: A DISCUSSION PAPER.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A global neuronopathic gaucher disease registry (GARDIAN): a patient-led initiative.
- Published in:
- Orphanet Journal of Rare Diseases, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13023-023-02828-w
- By:
- Publication type:
- Article
Histologic Findings of Femoral Heads From Patients With Gaucher Disease Treated With Enzyme Replacement.
- Published in:
- American Journal of Clinical Pathology, 2013, v. 140, n. 1, p. 91, doi. 10.1309/AJCPFVSAEGO67NGT
- By:
- Publication type:
- Article
Vitamin D Receptor (VDR) Polymorphisms in the Cardiac Variant of Gaucher Disease.
- Published in:
- Pediatric Cardiology, 2010, v. 31, n. 1, p. 30, doi. 10.1007/s00246-009-9538-7
- By:
- Publication type:
- Article
Effect of vitamin D receptor (VDR) genotypes on the risk for osteoporosis in type 1 Gaucher disease.
- Published in:
- 2010
- By:
- Publication type:
- Report
Comparison of Parkinson Risk in Ashkenazi Jewish Patients With Gaucher Disease and GBA Heterozygotes.
- Published in:
- JAMA Neurology, 2014, v. 71, n. 6, p. 752, doi. 10.1001/jamaneurol.2014.313
- By:
- Publication type:
- Article
Achievement of Therapeutic Goals with Low-Dose Imiglucerase in Gaucher Disease: A Single-Center Experience.
- Published in:
- Advances in Hematology, 2013, p. 1, doi. 10.1155/2013/151506
- By:
- Publication type:
- Article
Development and validation of Gaucher disease type 1 (GD1)-specific patient-reported outcome measures (PROMs) for clinical monitoring and for clinical trials.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Proof-of-principle rapid noninvasive prenatal diagnosis of autosomal recessive founder mutations.
- Published in:
- 2015
- By:
- Publication type:
- journal article
HCG contamination of alglucerase: Clinical implications in low-dose regimen.
- Published in:
- American Journal of Hematology, 1994, v. 47, n. 3, p. 235, doi. 10.1002/ajh.2830470317
- By:
- Publication type:
- Article
Dental profile of patients with Gaucher disease.
- Published in:
- BMC Oral Health, 2003, v. 3, p. 4, doi. 10.1186/1472-6831-3-4
- By:
- Publication type:
- Article
Disease severity in sibling pairs with type 1 Gaucher disease.
- Published in:
- Journal of Inherited Metabolic Disease, 2010, v. 33, n. 1, p. 79, doi. 10.1007/s10545-009-9024-7
- By:
- Publication type:
- Article
No justification for very high-dose enzyme therapy for patients with type III Gaucher disease.
- Published in:
- Journal of Inherited Metabolic Disease, 2007, v. 30, n. 6, p. 843, doi. 10.1007/s10545-007-0783-8
- By:
- Publication type:
- Article
Demographics and patient characteristics of 1209 patients with Gaucher disease: Descriptive analysis from the Gaucher Outcome Survey (GOS).
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. 205, doi. 10.1002/ajh.24957
- By:
- Publication type:
- Article
Seven-year safety and efficacy with velaglucerase alfa for treatment-naïve adult patients with type 1 Gaucher disease.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 7, p. 577, doi. 10.1002/ajh.24040
- By:
- Publication type:
- Article
Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long-term data from phase III clinical trials.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 7, p. 584, doi. 10.1002/ajh.24012
- By:
- Publication type:
- Article
Safety and efficacy results of switch from imiglucerase to velaglucerase alfa treatment in patients with type 1 Gaucher disease.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 7, p. 592, doi. 10.1002/ajh.24007
- By:
- Publication type:
- Article
Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double-blind, multinational, Phase 3 study.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 3, p. 166, doi. 10.1002/ajh.23381
- By:
- Publication type:
- Article
Safety and efficacy of velaglucerase alfa in Gaucher disease type 1 patients previously treated with imiglucerase.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 3, p. 172, doi. 10.1002/ajh.23383
- By:
- Publication type:
- Article
Enzyme replacement therapy for mild patients with Gaucher disease.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 4, p. 202, doi. 10.1002/ajh.21369
- By:
- Publication type:
- Article
Using the International Gaucher Disease Registry data: Can we devise a virtuous circle for treated patients?
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 12, p. 887, doi. 10.1002/ajh.21306
- By:
- Publication type:
- Article
Rheological determinants in patients with Gaucher disease and internal inflammation.
- Published in:
- American Journal of Hematology, 2004, v. 75, n. 4, p. 190, doi. 10.1002/ajh.20011
- By:
- Publication type:
- Article
D-dimer assay in Gaucher disease: Correlation with severity of bone and lung involvement.
- Published in:
- American Journal of Hematology, 2003, v. 73, n. 4, p. 236, doi. 10.1002/ajh.10361
- By:
- Publication type:
- Article
Platelet function abnormalities in Gaucher disease patients.
- Published in:
- American Journal of Hematology, 1999, v. 61, n. 2, p. 103, doi. 10.1002/(SICI)1096-8652(199906)61:2<103::AID-AJH5>3.0.CO;2-V
- By:
- Publication type:
- Article
Abdominal ultrasound findings mimicking hematological malignancies in a study of 218 gaucher patients.
- Published in:
- American Journal of Hematology, 1997, v. 55, n. 1, p. 28, doi. 10.1002/(SICI)1096-8652(199705)55:1<28::AID-AJH5>3.0.CO;2-5
- By:
- Publication type:
- Article
Prevention of Lysosomal Storage Diseases and Derivation of Mutant Stem Cell Lines by Preimplantation Genetic Diagnosis.
- Published in:
- Molecular Biology International, 2012, p. 1, doi. 10.1155/2012/797342
- By:
- Publication type:
- Article
Platelet adhesion defect in type I Gaucher Disease is associated with a risk of mucosal bleeding.
- Published in:
- British Journal of Haematology, 2011, v. 153, n. 3, p. 372, doi. 10.1111/j.1365-2141.2011.08613.x
- By:
- Publication type:
- Article
Aggregation of red blood cells in patients with Gaucher disease.
- Published in:
- British Journal of Haematology, 2006, v. 134, n. 4, p. 432, doi. 10.1111/j.1365-2141.2006.06199.x
- By:
- Publication type:
- Article
Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher disease.
- Published in:
- British Journal of Haematology, 2006, v. 133, n. 1, p. 93, doi. 10.1111/j.1365-2141.2006.05978.x
- By:
- Publication type:
- Article
Reply to weinreb.
- Published in:
- British Journal of Haematology, 2001, v. 113, n. 4, p. 1087, doi. 10.1046/j.1365-2141.2001.02821-12.x
- By:
- Publication type:
- Article
Reply to vom dahl et al.
- Published in:
- British Journal of Haematology, 2001, v. 113, n. 4, p. 1086, doi. 10.1046/j.1365-2141.2001.02821-10.x
- By:
- Publication type:
- Article
Withdrawal of enzyme replacement therapy in Gaucher's disease.
- Published in:
- British Journal of Haematology, 2000, v. 110, n. 2, p. 488, doi. 10.1046/j.1365-2141.2000.02177.x
- By:
- Publication type:
- Article
Ozone Administration Reduces Reperfusion Injury in an Isolated Rat Heart Model.
- Published in:
- Journal of Cardiac Surgery, 2007, v. 22, n. 4, p. 339, doi. 10.1111/j.1540-8191.2007.00419.x
- By:
- Publication type:
- Article